Explore our media
Learn more about ACTO and the life sciences industry at large through ACTO’s podcast, blogs, events, and more

Featured blogs

Episode 6 | Alison Muller
A Guide to AI & Automation for Field Excellence
February 3, 2026
AI for Field Excellence is everywhere—but clarity is not. Over the last few years, working closely with Life Sciences executives, we keep hearing variations of the same impossible equation: There is a massive Human Capital Gap between what field leaders are being asked to deliver and the human capital available to deliver. While AI seems like the obvious solution, “AI”

Episode 6 | Erin Abbatangelo
8 Launch Truths Emerging Biopharma Can’t Afford to Ignore
February 3, 2026
A modern guide to biopharma launch readiness, commercialization strategy, and sales execution for emerging biotech companies Launching a drug is not a victory lap. It’s a commercial stress test. For emerging biopharma companies, a pharmaceutical product launch is often the most consequential moment in the company’s history. After 10–15 years of development and billions of dollars invested, everything comes down
Pulse is your ultimate source of relevant and innovative strategy
Subscribe today to stay up to date in all thing industry
Subscribe
Recent Articles

Episode 6 | Alison Muller
A Guide to AI & Automation for Field Excellence
February 3, 2026
AI for Field Excellence is everywhere—but clarity is not. Over the last few years, working closely with Life Sciences executives, we keep hearing variations of the same impossible equation: There is a massive Human Capital Gap between what field leaders are being asked to deliver and the human capital available to deliver. While AI seems like the obvious solution, “AI”

Episode 6 | Erin Abbatangelo
8 Launch Truths Emerging Biopharma Can’t Afford to Ignore
February 3, 2026
A modern guide to biopharma launch readiness, commercialization strategy, and sales execution for emerging biotech companies Launching a drug is not a victory lap. It’s a commercial stress test. For emerging biopharma companies, a pharmaceutical product launch is often the most consequential moment in the company’s history. After 10–15 years of development and billions of dollars invested, everything comes down
